Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Teva
Novartis
Daiichi Sankyo
Harvard Business School
McKesson
Dow
US Department of Justice
Deloitte
Boehringer Ingelheim

Generated: August 23, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Aurobindo Pharma

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
16490AII3/28/2003AUROBINDO PHARMA LTDMIRTAZAPINE ANHYDROUS USP
16850AII9/19/2003AUROBINDO PHARMA LTDCITALOPRAM HYDROBROMIDE
16993AII12/1/2003AUROBINDO PHARMA LTDMETFORMIN HYDROCHLORIDE USP
17152AII1/20/2004AUROBINDO PHARMA LTDGLYBURIDE USP
17217III3/5/2004AUROBINDO PHARMA LTDAMIODARONE HYDROCHLORIDE
17435AII5/31/2004AUROBINDO PHARMA LTDSERTRALINE HYDROCHLORIDE USP (CRYSTALLINE POLYMORPH FORM II)
17562III7/5/2004AUROBINDO PHARMA LTD7-AMINO DESACETOXY CEPHALOSPORANIC ACID (7-ADCA)
17570AII7/16/2004AUROBINDO PHARMA LTDRAMIPRIL USP
17604AII7/31/2004AUROBINDO PHARMA LTDCEPHALEXIN USP
17638AII8/18/2004AUROBINDO PHARMA LTDZIDOVUDINE USP
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Daiichi Sankyo
Chinese Patent Office
Deloitte
UBS
Fish and Richardson
Cipla
Novartis
Cantor Fitzgerald
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot